Drugs / rBet v 1
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 12 trials | ||||||
| Phase 1 | NCT00889460 | Nov 2007 → Apr 2008 | seasonal allergic rhinitis | Stallergenes Greer | Completed | No outcome recorded |
| Phase 1 | NCT00396149 | Nov 2006 → Mar 2007 | seasonal allergic rhinitis | Stallergenes Greer | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT00901914 | Oct 2008 → Jun 2009 | seasonal allergic rhinitis | Stallergenes Greer | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT01449786 Comparator | Mar 2012 → Feb 2014 | — | Medical University of Vienna | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | rBet v 1 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00396149 ↗ |
| Modality | Protein / enzyme biologic | “With Recombinant Bet v1” NCT00396149 ↗ |
| Route | Other | “Sublingual Immunotherapy” NCT00396149 ↗ |